PETS Petmed Express Inc

Price (delayed)

$4.84

Market cap

$102.35M

P/E Ratio

N/A

Dividend/share

$1.2

EPS

-$0.29

Enterprise value

$50.72M

Founded in 1996, PetMed Express is America's Most Trusted Pet Pharmacy, delivering prescription and non-prescription pet medications and other health products for dogs, cats, and horses at competitive prices direct ...

Highlights
PETS's debt is down by 11% since the previous quarter
The revenue has grown by 3.1% YoY and by 2.1% from the previous quarter
The quick ratio has plunged by 57% YoY but it has grown by 23% from the previous quarter
The company's net income has shrunk by 139% YoY and by 77% QoQ
Petmed Express's EPS has shrunk by 137% YoY and by 81% QoQ

Key stats

What are the main financial stats of PETS
Market
Shares outstanding
21.15M
Market cap
$102.35M
Enterprise value
$50.72M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.9
Price to sales (P/S)
0.36
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.19
Earnings
Revenue
$270.52M
EBIT
-$6.45M
EBITDA
-$1.12M
Free cash flow
$17.42M
Per share
EPS
-$0.29
Free cash flow per share
$0.85
Book value per share
$5.37
Revenue per share
$13.27
TBVPS
$5.87
Balance sheet
Total assets
$159.27M
Total liabilities
$45.6M
Debt
$1.84M
Equity
$113.67M
Working capital
$44.97M
Liquidity
Debt to equity
0.02
Current ratio
2.1
Quick ratio
1.37
Net debt/EBITDA
45.94
Margins
EBITDA margin
-0.4%
Gross margin
27.8%
Net margin
-2.2%
Operating margin
-3.9%
Efficiency
Return on assets
-3.6%
Return on equity
-5%
Return on invested capital
-26.8%
Return on capital employed
-5.4%
Return on sales
-2.4%
Dividend
Dividend yield
24.79%
DPS
$1.2
Payout ratio
N/A

PETS stock price

How has the Petmed Express stock price performed over time
Intraday
-0.62%
1 week
0.21%
1 month
-6.2%
1 year
-69.58%
YTD
-35.98%
QTD
-35.98%

Financial performance

How have Petmed Express's revenue and profit performed over time
Revenue
$270.52M
Gross profit
$75.21M
Operating income
-$10.45M
Net income
-$6.08M
Gross margin
27.8%
Net margin
-2.2%
The operating income has plunged by 156% YoY and by 48% from the previous quarter
The company's operating margin has shrunk by 155% YoY and by 44% QoQ
The company's net income has shrunk by 139% YoY and by 77% QoQ
PETS's net margin has dropped by 137% year-on-year and by 69% since the previous quarter

Growth

What is Petmed Express's growth rate over time

Valuation

What is Petmed Express stock price valuation
P/E
N/A
P/B
0.9
P/S
0.36
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.19
Petmed Express's EPS has shrunk by 137% YoY and by 81% QoQ
The price to book (P/B) is 75% lower than the 5-year quarterly average of 3.6 and 64% lower than the last 4 quarters average of 2.5
The equity has declined by 18% year-on-year and by 3.9% since the previous quarter
The P/S is 79% below the 5-year quarterly average of 1.7 and 67% below the last 4 quarters average of 1.1
The revenue has grown by 3.1% YoY and by 2.1% from the previous quarter

Efficiency

How efficient is Petmed Express business performance
PETS's ROE has plunged by 145% YoY and by 85% from the previous quarter
The ROIC has plunged by 144% YoY and by 120% from the previous quarter
The company's return on assets has shrunk by 139% YoY and by 80% QoQ
Petmed Express's return on sales has shrunk by 131% YoY and by 100% QoQ

Dividends

What is PETS's dividend history
DPS
$1.2
Dividend yield
24.79%
Payout ratio
N/A
Recent dividends

Financial health

How did Petmed Express financials performed over time
The quick ratio has plunged by 57% YoY but it has grown by 23% from the previous quarter
The current ratio has plunged by 54% YoY but it has grown by 14% from the previous quarter
PETS's debt is 98% smaller than its equity
The equity has declined by 18% year-on-year and by 3.9% since the previous quarter
PETS's debt is down by 11% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.